Raffaella Fittipaldi
Via Celoria 26
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development.
Journal: Cells
Published: March 31, 2021
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy.
Journal: Nature communications
Published: June 20, 2019
SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
Journal: Nucleic acids research
Published: November 19, 2017
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.
Journal: Nature communications
Published: January 15, 2017
Vitamin D and VDR in cancer cachexia and muscle regeneration.
Journal: Oncotarget
Published: July 28, 2016
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth.
Journal: Journal of cellular physiology
Published: December 23, 2014
The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.
Journal: Genes & development
Published: June 12, 2013
Tackling skeletal muscle cells epigenome in the next-generation sequencing era.
Journal: Comparative and functional genomics
Published: February 03, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026